IFN-α treatment recently showed to inhibit VEGF expression or secretion in several tumour types in vitro and in vivo (Rosewicz et al, 2004; Wu et al, 2005; Raig et al, 2008; Tochizawa et al, 2008). Here, IFNA1 is linked to neoplasm.